Afuco™ Anti-Human NONO ADCC Recombinant Antibody (PAT-LM1), ADCC Enhanced (CAT#: AFC-660CL)

Anti-NONO ADCC Enhanced Antibody (PAT-LM1) is an ADCC enhanced antibody produced by our Afuco™ platform. PAT-LM1 bingding to non-POU domain-containing octamer-binding protein (NONO) is a natural human antibody that can be used as a potential treatment for multiple types of cancer, with a particularly strong potency against colon, lung, breast, ovary, pancreatic cancers, lympoma.

Specific Inquiry
  • Size:

  • Conjugation:

  • Endotoxin:

  • Purity:

  • Formats:

  • Isotype Switching:

  • Fc Engineering:

  • Modalities:

Custom Production

We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.

Sequences:
Isotype :
Purity :
Endotoxin :
Quantity :
Conjugation :
Fc Engineering :
Modalities :
Other Requirements:
We require custom production
  • Published Data
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
MTT assay

Figure 4 show a series of graphs of the results of MTT reduction assays for mitochondrial dehydrogenase activity.

Figure 4 show a series of graphs of the results of MTT reduction assays for mitochondrial dehydrogenase activity.

The LM-I monoclonal antibody inhibits cell proliferation and decreases survival, or induces apoptosis of EPLC-272H epidermoid cell carcinoma of the lung cells after A) 24 hours of incubation; and B) 48 hours of incubation.

FuncS

Figure 5 shows a graph showing that the LM-I antibody induces apoptosis.

Figure 5 shows a graph showing that the LM-I antibody induces apoptosis.

A series of graphs of the results of a cell death ELISA showing that the LM-1 monoclonal antibody induces apoptosis of LOU-NH91 cells after A) 24 hours of incubation; and B) 48 hours of incubation.

Figure 6 The results of screening for antibody LM-I binding to oligosaccharides.

Figure 6 The results of screening for antibody LM-I binding to oligosaccharides.

FuncS

Figure 7 shows body weight of LM-I injected mice, which was maintained for 8 weeks post injection.

Figure 7 shows body weight of LM-I injected mice, which was maintained for 8 weeks post injection.

Body weight in the no injection control and non-specific IgM injected control was reduced by almost 20%, due to poor health from liver metastasis.

Figure 8 shows data indicating that LM-I antibody can reduce tumor metastasis establishment, formation, or proliferation (growth).

Figure 8 shows data indicating that LM-I antibody can reduce tumor metastasis establishment, formation, or proliferation (growth).


Specifications

  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Applications
  • WB, ELISA, FC, MTT assay
  • Related Disease
  • Colon Cancer; Lung Cancer; Breast Cancer; Ovary Cancer; Pancreatic Cancers; Lympoma

Product Property

  • Purity
  • >95% as judged by SDS-polyacrylamide gel electrophoresis
  • Storage
  • Store at -20°C. Open under aseptic conditions.

Applications

  • Application Notes
  • The antibody was validated for Western Blot, ELISA, Flow Cytometry, MTT assay. For details, refer to Published Data.

Target

  • Alternative Names
  • NONO; non-POU domain-containing octamer-binding protein

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "NONO"

Select a product category from the dropdown menu below to view related products.
Please select product type
IgG Antibody Products IgM Antibody Products Human Antibody Products Rabbit Monoclonal Antibody Products ScFv Antibody Products Fab Antibody Products

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for AFC-660CL. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare